Mobius Life Sciences

mobius-portfolio

Portfolio

Mobius Life Sciences' Investments

Compandx

CompanDX

CompanDX holds the key to value generation in the exciting new field of Personalised Medicine....

Keep Reading...

Xenogesis

XenoGesis Ltd. is a laboratory-based contract research organisation (CRO) specialised in preclinical drug metabolism &...

Keep Reading...

Cellaura Technologies

CellAura Technologies is the premier source of innovative fluorescent screening products for life science research...

Keep Reading...

Haemostatix

Haemostatix is developing first-in-class clotting agents for the treatment of bleeding or ‘haemostasis’. The company...

Keep Reading...

R5 Pharmaceuticals

R5 Pharmaceuticals

BioCity Nottingham also invested in R5 Pharmaceuticals and the company was subsequently sold
© Mobius Life Sciences 2013 Web site design by OLIK